Abstract
Chronic liver disease is the 11th leading cause of mortality in the United States.1 Portal hypertension is a common endpoint for progressive liver disease, and can clinically manifest as refractory ascites, splenomegaly, and life-threatening esophageal and gastric variceal bleeding. Transjugular intrahepatic portosystemic shunt (TIPS) is an endovascular procedure that treats portal hypertension by making a connection between the portal and systemic venous systems. By creating a low-resistance outflow tract for portal venous drainage, TIPS decreases portal hypertension and its dangerous sequelae in patients not responding to medical therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
